These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37109593)

  • 21. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.
    Park Y; Kim D; Yang JH; Cho YH; Choi JO; Jeon ES
    Korean J Intern Med; 2022 Mar; 37(2):340-349. PubMed ID: 34871480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.
    Gustafsson F; Rogers JG
    Eur J Heart Fail; 2017 May; 19(5):595-602. PubMed ID: 28198133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS.
    Michelis KC; Zhong L; Peltz M; Pandey A; Tang WHW; Rohatgi A; Young JB; Drazner MH; Grodin JL
    J Am Heart Assoc; 2020 Jul; 9(14):e016203. PubMed ID: 32648531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.
    Atluri P; Goldstone AB; Fairman AS; MacArthur JW; Shudo Y; Cohen JE; Acker AL; Hiesinger W; Howard JL; Acker MA; Woo YJ
    Ann Thorac Surg; 2013 Sep; 96(3):857-63; discussion 863-4. PubMed ID: 23791165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support.
    Hanff TC; Birati EY
    Curr Heart Fail Rep; 2019 Oct; 16(5):168-179. PubMed ID: 31631240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
    Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
    J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term assist device patients admitted to ICU: Tips and pitfalls.
    Morshuis M; Fox H; Lauenroth V; Schramm R
    J Intensive Med; 2023 Apr; 3(2):81-88. PubMed ID: 37188121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shared Care to Destination Therapy Left Ventricular Assist Device Site: a Novel Strategy to Start a Successful Mechanical Circulatory Support Program.
    Shah M; Hafeez Y; Burns P; Toyoda Y; Moshiyakhov M; Neary M; Ross R; Chichetti J; Muzaffar A; Barn K
    Curr Cardiol Rep; 2021 Jul; 23(8):112. PubMed ID: 34264422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
    Rogers JG; Aaronson KD; Boyle AJ; Russell SD; Milano CA; Pagani FD; Edwards BS; Park S; John R; Conte JV; Farrar DJ; Slaughter MS;
    J Am Coll Cardiol; 2010 Apr; 55(17):1826-34. PubMed ID: 20413033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Third Annual Report From the ISHLT Mechanically Assisted Circulatory Support Registry: A comparison of centrifugal and axial continuous-flow left ventricular assist devices.
    Goldstein DJ; Meyns B; Xie R; Cowger J; Pettit S; Nakatani T; Netuka I; Shaw S; Yanase M; Kirklin JK
    J Heart Lung Transplant; 2019 Apr; 38(4):352-363. PubMed ID: 30945637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Destination therapy: the new gold standard treatment for heart failure patients with left ventricular assist devices.
    Yamakawa M; Kyo S; Yamakawa S; Ono M; Kinugawa K; Nishimura T
    Gen Thorac Cardiovasc Surg; 2013 Mar; 61(3):111-7. PubMed ID: 23264080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD).
    Chatterjee A; Feldmann C; Hanke JS; Ricklefs M; Shrestha M; Dogan G; Haverich A; Schmitto JD
    J Thorac Dis; 2018 Jun; 10(Suppl 15):S1790-S1793. PubMed ID: 30034854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical circulatory support devices as destination therapy-current evidence.
    Puehler T; Ensminger S; Schoenbrodt M; Börgermann J; Rehn E; Hakim-Meibodi K; Morshuis M; Gummert J
    Ann Cardiothorac Surg; 2014 Sep; 3(5):513-24. PubMed ID: 25452913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study.
    Warraich HJ; Allen LA; Blue LJ; Chaussee EL; Thompson JS; McIlvennan CK; Flint KM; Matlock DD; Patel CB
    Am Heart J; 2019 Jul; 213():91-96. PubMed ID: 31129442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right.
    Bayes-Genis A; Muñoz-Guijosa C; Santiago-Vacas E; Montero S; García-García C; Codina P; Núñez J; Lupón J
    Eur Cardiol; 2020 Feb; 15():e19. PubMed ID: 32419850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rise of the machines? Left ventricular assist devices for treatment of severe heart failure].
    Ujeyl A; Krüger M
    Herz; 2015 Nov; 40(7):972-9. PubMed ID: 26530283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dying With a Left Ventricular Assist Device as Destination Therapy.
    Dunlay SM; Strand JJ; Wordingham SE; Stulak JM; Luckhardt AJ; Swetz KM
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.